Learn about new requirements and reimbursement changes.Read More »
Gain insights into CMS' proposals for the 340B drug discount program.Read More »
Revenue integrity professionals came together for two days of empowering learning and networking at the 2025 Revenue Integrity Symposium (RIS).Read More »
One of the most common errors seen in skin substitute claims is the inappropriate application of drug waste modifiers, which are as follows:
Review recent billing and coding updates concerning critical care, telehealth, and other evaluation and management (E/M) services.Read More »
Q: How can we improve correct use of drug waste modifiers on skin substitute claims?Read More »
Knowing whether you’re on the right track to advance your career isn’t easy—especially for revenue integrity professionals.Read More »
Revenue integrity professional should take note of recent updates to CMS’ Medicare Preventive Services educational tool.Read More »